baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Aktienanleihe AMD 28.06.2024/ DE000VU68U53 /

28/05/2024 08:52:59	Chg.-0.03	Bid22:00:43	Ask22:00:43	Underlying	Strike price	Expiration date	Option type
101.13EUR	-0.03%	- Bid Size: -	- Ask Size: -	Advanced Micro Devic...	100.00 USD	28/06/2024	Call

GlobeNewswire 28/05 AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024

GlobeNewswire 28/05 FreeBSD Foundation Marks Record Growth and Partner Investments

GlobeNewswire 28/05 Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...

GlobeNewswire 28/05 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

GlobeNewswire 21/05 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...

GlobeNewswire 21/05 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...

GlobeNewswire 21/05 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...

GlobeNewswire 21/05 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)

TeleTrader 20/05 Microsoft will 'soon welcome' AMD, Intel chips

GlobeNewswire 20/05 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs

Newsfile Corp 16/05 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization

GlobeNewswire 15/05 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...

GlobeNewswire 14/05 AMD Announces Upcoming Events for the Financial Community

GlobeNewswire 14/05 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...

GlobeNewswire 14/05 Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

GlobeNewswire 14/05 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 13/05 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...

GlobeNewswire 13/05 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...

GlobeNewswire 09/05 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 09/05 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...

GlobeNewswire 09/05 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 08/05 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...

GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 08/05 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...

GlobeNewswire 08/05 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

BVT Aktienanleihe AMD 28.06.2024/ DE000VU68U53 /

If you wish to receive reply to your feedback, please provide your email address.